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Abstract 
 
Objective(s) 
Mesenchymal stem cells (MSCs) from large animals as goat which is genetically more closely related to 
human have rarely been gained attentions. The present study tried to isolate and characterize MSCs from 
goat bone marrow.   
Materials and Methods 
Fibroblastic cells appeared in goat marrow cell culture were expanded through several subcultures. 
Passaged-3 cells were then differentiated among the osteogenic, adipogenic and chondrogenic cell lineages 
to determine their MSC nature. Differentiations were determined by RT-PCR analysis of related gene 
expression. To identify the best culture conditions for propagation, passage-3 cells were plated either at 
varying cell densities or different fetal bovine serum (FBS) concentrations for a week, at the end of which 
the cultures were statistically compared with respect to the cell proliferation. In this study, we also 
determined goat MSC population doubling time (PDT) as the index of their in vitro expansion rate.  
Results 
Passage-3 fibroblastic cells tended to differentiate into skeletal cell lineages. This was evident in both 
specific staining as well as the specific gene expression profile. Moreover, there appeared to be more 
expansion when the cultures were initiated at 100 cells/cm
2 in a medium supplemented with 15% FBS. A 
relatively short PDT (24.94±2.67 hr) was a reflection of the goat MSC rapid rate of expansion. 
Conclusion  
Taken together, fibroblastic cells developed at goat marrow cell culture are able to differentiate into skeletal 
cell lineages. They undergo extensive proliferation when being plated at low cell density in 15% FBS 
concentration. 
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Introduction 
Mesenchymal stem cells (MSCs) possess two 
fundamental characteristics: the ability of 
extensive replication and the capacity of 
multilineage differentiation among bone, 
cartilage and adipose cell lineages. These cells 
have been reported to be present in bone 
marrow and several other tissues in adult (1). 
MSCs were first described by Friedenstein and 
co-workers who have reported the isolation of 
the cells from rat bone marrow tissue, using 
the cell plastic-adherent property (2). Since 
then, this property has been used to isolate and 
characterize MSCs from a number of species 
including dog, rabbit, pig, baboon and human 
(3-7). Having the ability of self-renewal for 
long-term along with multilineage 
differentiation potential have rendered MSCs 
as significant cellular materials for tissue 
regeneration applications (8).  
Two important challenges associated with 
MSCs would be the topics of their safety and 
efficacy in use as therapeutic tool for tissue 
regeneration. These subjects need sufficient 
investigation in animal models, which in turn 
requires MSCs isolation and characterization, 
as the first step, from the interest animal. In 
this regards, most related investigation has so 
far been carried out in small animal as rodents 
(9). MSCs from large animals as goat which is 
more similar to human than rodents has rarely 
gained attention. MSCs biology in this animal 
has indeed remained to be fully investigated. 
In those research works associated with goat 
MSCs, the cells isolated from the animal 
marrow have mostly been used to establish 3D 
cultures in scaffolds without taking into 
account the cell in vitro characteristics as well 
as culture requirements. In this regards, Nair  
et al (2008) have manufactured a triphasic 
scaffolds consisting of hydroxyapatite, 
tricalcium phosphate and calcium silicate and 
evaluated the scaffold biocompatibility with 
goat MSCs 3D culture (10). In a similar 
investigation, Li and colleagues have used 
goat MSCs for biocompatibility test of newly 
manufactured hydrogel scaffolds (11). 
Williams  et al have investigated the 
chondrogenic potential of goat MSCs within 
hydrogel in vitro (9). Dai et al have used goats 
as animal model to evaluate the regenerative 
capacity of goat MSCs-loaded scaffolds in 
bone large defects (12). Neither of these 
experiments has examined the multipotent 
differentiation capacity of the isolated cells 
which MSC committee of international society 
of cell therapy has announced it as defining 
criterion for MSCs (13). In the present study, 
this subject was examined. 
Carrying out the differentiation analysis with 
RT-PCR, we noticed that a number of specific 
genes for goat bone, cartilage and adipose cell 
were not registered in gene database of NCBI. 
As a solution, we designed and used the 
primers for equine corresponding genes 
(which were available in gene database) to 
amplify the goat genes; and then the 
amplification product was extracted, 
sequenced and investigated whether or not 
they were similar to corresponding genes in 
close species to goat. All sequences were then 
registered in NCBI gene database. Accession 
numbers were assigned to the sequences which 
are currently available. Moreover, in this study, 
culture conditions for the maximum 
proliferation of goat MSCs were optimized.  
 
Materials and Methods 
Bone marrow cell culture 
Four male adult goats of Najdi strain were 
used in this study. Before experiments, 
approval of the animal use was obtained from 
the Ethic Committee of Royan Institute. The 
animals were kept in the facility of Royan 
institute (Karaj, Iran) till become acclimatized 
to housing and diet. Under general anesthesia 
by Ketamine (22 mg/kg) and xylazine (0.2 
mg/kg) IM injection, bone marrow aspirate 
(about 10 ml) were drawn from the tibia, 
collected into 50 ml tube containing 7500 unit 
heparin and shipped on the ice to cell culture 
facility of Royan Institute. Bone marrow 
aspirates were added  to 5 ml DMEM medium 
(Dulbeccoo’s modified eagle medium, Sigma, 
USA) supplemented with 100 IU/ml penicillin 
(Sigma, USA), 100 IU/ml streptomycin  
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(Sigma, USA), 10% FBS (Fetal Bovine 
Serum) and centrifuged at 300 g for 5 min. 
Supernatant was discarded, cell pellet 
resuspended in 1 ml DMEM medium and 
plated at 5×10
6 cells/cm
2 in 75-cm
2 culture 
flasks in an atmosphere of 5% CO2 and 37 °C. 
About 3-4 days after culture initiation, culture 
medium was replaced with fresh DMEM and 
the flasks were incubated with a medium 
replacement of 2 times a week until the 
cultures became confluent. At this stage, cells 
were trypsinized and subcultured at 5×10
5 
cells/cm
2. Cell passages were repeated up to 
the subculture 3 when sufficient cells were 
available to continue the experiments 
described below. 
 
Differentiation potential 
To evaluate the mesenchymal stem cell nature, 
the isolated cells were differentiated into 
osteogenic, chondrogenic and adipogenic cell 
lineages. 
To induce osteogenic differentiation, 
confluenced passaged-3 cells were cultured in 
the      DMEM  medium  supplemented  with         
50 mg/ml ascorbic 2- phosphate (Sigma, USA), 
10  nM  dexamethasone  (Sigma,  USA)  and            
10 mM β glycerol phosphate ( Sigma, USA) 
for 3 weeks (14-15). At the end of this period, 
alizarin red staining was used to observe the 
matrix mineralization. For staining, the 
cultures  were  first  fixed  by  methanol  for        
10 min and then subjected to alizarine red 
solution for 2 min.  
For adipogenesis, DMEM medium 
containing 100 nM dexamethasone (Sigma, 
USA) and 50 mg/ml indomethacin (Sigma, 
USA) was used to induce the differentiation in 
the confluent culture of passaged-3 cells             
(14, 15). Three weeks after culture initiation, 
the cells were fixed with 4% formalin at room 
temperature, washed by 70% ethanol and 
stained, using oil red solution in 99% 
isopropanol for 15 min. 
To induce the cartilage differentiation, micro 
mass culture system was used. For this 
purpose, 2.5×10
5 passaged-3 cells were 
pelleted under 300 g for 5 min and cultured in 
a DMEM medium supplemented by 10 ng/ml 
TGF- ß3 (transforming growth factor-ß3) 
(Sigma, Germany), 10 ng/ml BMP6 (bone 
morphogenetic protein-6) (Sigma, Germany), 
50 mg/ml insulin transferin selenium+ premix 
(Sigma, Germany) and 1.25 mg bovine serum 
albumin (Sigma, Germany) and 1% fetal 
bovine serum (15,16). Three weeks after 
initiation of the culture, the pellets were 
removed and subjected to the following: fixing 
in 10% formalin; dehydrating in ascending 
concentrations of ethanol; clearing in xylene; 
embedding in paraffin wax and sectioning at             
5 µm by microtome. The sections were then 
stained, using toluidine blue for 30 sec at room 
temperature.  
 
RT-PCR analysis 
Primers 
Because of the lack of a number of specific 
gene sequences for goat osteocyte, 
chondrocyte and adipocyte (except for 
GAPDH and Osteocalcin), we designed the 
primers for equine bone, cartilage and adipose-
specific genes which were available in NCBI 
gene Database and used them in order to 
amplify the genes in goat differentiated 
cultures. The bands of amplified fragments 
were recovered from the gel by QIA quick
® 
Gel Extraction kit and then sequenced by 
Chromas Software version 2.31. BLAST 
results of these sequences, showed that there 
are many similarities between them and 
sequences related to the genes of other species 
close to goat. Therefore, it confirmed that the 
equine specific primers were able to amplify 
our interest fragments in goat genome. 
Sequenced gene fragments were registered in 
NCBI gene database and they were assigned 
the accession numbers. The similarity 
percentage of these sequences to the sequences 
of other species and also primer sequences 
used to amplify the interest genes are indicated 
in Table 1 and 2, respectively. The sequences 
that have been registered at NCBI gene 
database for goat are shown in Table 3. 
Table 1. The similarity percentage of amplified sequences from ovine differentiated cultures, using equine primers 
compared with those of other species.  
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Similarity 
percentage  
Other species    Similarity 
percentage   
Other species    Gene name   
91    Equus caballus    97    Bos taurus    Aggrecan   
100    Equus caballus    98    Bos taurus    Collagen II   
90    Equus caballus    93    Bos taurus    Peroxisome proliferator-activated 
receptor alpha (PPARA)   
93    Equus caballus    99    Bos taurus    Peroxisome proliferator-activated 
receptor gamma (PPARG)   
90   Equus caballus    99    Bos taurus    Lipoprotein lipase   
97   Equus caballus   97    Bos taurus    Collagen 1  
 
 
 Table 2.  Primers used in RT-PCR analysis, * indicates the genes that were not found in NCBI gene database. These 
genes were sequenced in this study and registered at NCBI gene database. Their accession numbers indicated in the left 
column are now available in the database. 
 
 
RT-PCR Procedure 
Total RNA was isolated, using the RNX
TM           
(-Plus) (RN7713C; CinnaGen Inc., Tehran, 
Iran). Before RT, a sample of the isolated RNA 
was treated with 1U/ml of RNase-free DNaseI 
(EN0521; Fermentas, Opelstrasse 9, Germany) 
per 1 mg of  RNA in order to eliminate residual 
DNA in the presence of 40 U/ml of ribonuclease 
inhibitor (E00311; Fermentasm, Germany) and 
1×reaction buffer with MgCl2  for  30  min  at         
37 
◦C. To inactivate the DNaseI, 1 ml of 25 
mM EDTA was added and incubated at 65 
◦C 
for 10 min. Standard RT Reactions were 
performed with 2 µg total RNA, using 
Random hexamer as a primer designed for 
equine genes and a designed for equine genes 
and a RevertAid
TM First Strand cDNA Synthesis 
Kit (K1622; Fermentas, Germany) according to 
the manufacturer’s instructions. For every 
reaction set, one RNA sample was prepared 
without RevertAid
TMM-MuLV  Reverse 
Transcriptase (RT 
- reaction) to provide a 
negative control in the subsequent PCR. To 
minimize variation in the RT reaction, all RNA 
samples from a single experimental set up were 
reverse transcribed simultaneously. Reaction 
mixtures for PCR included 2 ml cDNA, 1×PCR 
buffer (AMS
TM; CinnaGen Co., Tehran, Iran), 
200 mM dNTPs, 0.5 mM of each antisense and 
sense primer, and 1U Taq DNA polymerase. 
PCR was performed, using Mastercycler 
Gradient 5331, Ependorf, Hamburg, Germany. 
 
Table 3. The sequences of goat bone, cartilage and adipose genes that have been registered in NCBI gene database by 
the authors. The Accession numbers that have been devoted to these sequences are indicated in Table 2. 
A.T   Primer sequence   Gene name    Accession number    
59   F: 5' ttg gac ttt ggc aga ata cc 3'  
R: 5' ctt cca cca atg tcg tat cc 3'   
Aggrecan*    FJ178373   1  
58   F: 5' gcg gag act act gga ttg  
R: 5' ttt ctt gtc ctt gct ctt gc 3'   
Collagen II*    FJ178374    2  
60   F: 5' agaacaaggaagcggaagtc 3'  
R: 5' atcccgtctttgttcatcac 3'   
peroxisome proliferator-activated 
receptor alpha (PPAR a)*   
FJ200435    3  
60   F: 5' aagagcagagcaaagaggtg 3'  
R: 5' gggcttcacattcaacaaac 3'  
peroxisome proliferator-activated 
receptor gamma( PPAR g)   
FJ178372    4  
58   F: 5’ ccc aga aca tca cct acc ac 3’  
R: 5’ gga ggg agt tta cag gaa gc 3’   
Collagen1*    FJ200436    5  
59   F: 5' tct ctt ggg ata cag cct tg 3'  
R: 5' atg ccc tac tgg ttt ctg 3'   
LPL*   FJ200437   6   
62   F: 5' act gag cga tac caa aca cc 3'  
R: 5' ggt cca ttt agt cct ctc tcc 3'   
Collagen type X   XM001504101.1  7  
60   F: 5' gga gaa acc tgc caa gta tg 3'  
R: 5' tga gtg tcg ctg ttg aa gtc 3'   
GAPDH   DQ152956.1   8  
61   F: 5' agc gag gtg gtg aag aga c 3'  
R: 5' gct cat cac agt cag ggt tg 3'  
Osteocalcin   NM_001040009.1   9  
54   F: 5' ttg atg gtg cta ctt tga a 3' 
R: 5' aac atc ctc ctt caa cag c 3' 
Collagen type III   XM_001917620.1   10   
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Aggrecan  
 
ttggactttg gcagaatacc ttctgtaact ttaggaagtg ggcaagctcc agaagcaagt ggtcttcctt ctggatttag tggtgagtat 
tctggggtgg accttggaag tggcccatcc tctggccttc ctgatctaag tggacttcca tctgggttcc caactgtctc tctggtggat 
acgacattgg tggaaga   
Collagen II  
 
cggagactac tggatcgacc ccaaccaggg ctgcaccctg gatgccatga aggttttctg caacatggag actggcgaga cctgcgtcta 
ccccaacccg gccagcgtcc ccaagaagaa ctggtggagc agcaagagca aggacaagaaa   
Collagen I  
 
ggtgggaggt gacaggaagt cccagaacat cacctaccac tgcaagaaca gcgtggccta catggaccag cagaccggca 
acctcaagaa ggccctgctc ctccagggct ccaacgagat cgagattcgg gccgagggca acagccgctt cacctacagc 
gtcacctacg atggctgcac gagtcacacc ggagcctggg gcaagacagt gatcgaatac aaaaccacca agacctcccg cttgcccatc 
atcgatgtgg ctcccttgga cgttggcgcc ccagaccagg aattcggctt cgacatcggc tctgtctgct tcctgtaaac tccctcca   
LPL   ttctcttggg atacagcctt ggggcccatg ctgctggtat tgcaggaagt ctgaccaata agaaggtcaa caggattacc ggcctagatc 
cggctggacc taacttcgag tatgcagaag ctccaagtcg cctttctccc gatgacgcgg attttgtaga tgttttacac acgttcacca 
gggggtcacc tggccgaagt atcggaatcc agaaaccagt agggcatt   
PPARgamma  
 
aagagcagag caaagaggtg gccatccgca tcttccaggg gtgtcagttt cgctccgtgg aagccgtgca ggagatcaca 
gagtacgcca agaatatccc cggctttgtg aaccttgact tgaacgacca agtaactctc ctaaaatacg gcgtgcacga gatcatttac 
acgatgctgg cctccttgat gaacaaggat ggggtcctca tatccgaggg ccaaggattc atgacaaggg agtttctaaa gagcctgcga 
aagccctttg gtgactttat ggagcccaag ttcgagtttg ctgtgaagtt caacgcactg gaattagatg acagcgactt agcaatattt 
atagctgtca ttattctcag tggagaccgc ccaggtttgt tgaatgtgaa gccc   
PPAR alpha  
 
Agaacaagga agcggaagtc cgcatcttcc actgctgcca gtgcacgtct  gtggagaccg tcaccgagct cacggagttc 
gccaagtcca tcccagggtt    tgcaagcttg gacttgaacg accaggtcac cctgctgaag tatggcgttt   acgaagccat   
atttgcgatg ctgtcttctg tgatgaacaa agacgggata   
 
 
 
Optimizing the culture condition for 
maximum proliferation  
In this study, initiating cell seeding density and 
FBS concentration in medium were optimized 
for extensive proliferation of the cells. For this 
purpose, the isolated cells (passage-3) were 
plated in a 100-mm dish  at varying densities 
of 10, 50, 100, 200 and 500 cell/cm
2 in 
DMEM,  supplemented with 100 IU/ml 
penicillin, 100 mg/ml streptomycin  and 10% 
fetal calf serum for a week. At the end of this 
period, the cells were lifted, counted and the 
fold increase number was calculated and 
compared statistically (One-way ANOVA). 
Likewise, the cultures of passage-3 cells were 
established with 100 cell/cm
2 in DMEM, 
supplemented with 100 IU/ml penicillin, 100 
mg/ml streptomycin and such varying 
concentrations of FCS as 5%, 10%, 15% and 
20% for one week. Subsequently, the fold 
increase number of the cells was calculated in 
each group and compared by means of One-
way ANOVA. 
 
CFU- F (colony forming unit- fibroblast) 
assay 
Hundred cells of the passage-3 culture were 
plated in a 25-cm
2 plastic flask in DMEM, 
supplemented with 100  IU/ml  penicillin,  100  
 
mg/ml streptomycin and 10% fetal calf serum 
before they were incubated at 37 °C and 5% 
CO2 for 6 days. At the end of the cultivation 
period the number of the clones was counted 
under an inverted microscope. 
 
Population doubling time (PDT)  
After the optimal cell seeding density and FBS 
concentrations were determined, the cells 
cultivated under these conditions and their 
PDT was calculated. For this purpose, 
passaged-3 cells were plated at 100 cells/cm
2 
in a DMEM supplemented with 15% FBS and 
incubated for a period of 7 days, when the 
cultures terminated, the cells lifted and 
counted with hemocytometer. Using the 
following equation, PDT was determined. In 
this equation N is the initiating cell number, 
N0 the harvesting cell number and CT stands 
for culture time. 
 
 
 
(PDT) = 
31 . 3
0
×
N
N
Log
CT
 
 
Results 
Cell culture 
The primary cultures of the goat bone marrow 
cells contained mainly fibroblastic cells as 
well as a few small round cells. The number of 
latter was reduced by performing subcultures, 
during which the fibroblastic MSCs were 
purified and became dominant in the culture 
(Figure 1).  
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Figure 1. Goat marrow cell culture. At primaty culture, 
fibroblastic as well as small clear cells can be observed. 
The number of clear cells was decreased during the 
passages and fibroblastic cells became dominant in 
culture. 
 
Multi-lineage differentiation 
In osteoinductive cultures, in some areas, 
nodule-like structures were observed. 
Following alizarin red staining, red 
mineralizing areas of cultures appeared 
(Figure 2A). Differentiation was further 
demonstrated by RT-PCR analysis of the 
osteocytic markers. After a 3-week induction 
period, osteocalcin and collagen I and III 
mRNA  levels  were  largely  produced           
(Figure 2B). 
Nodular structures were not observed at 
adipogenic culture. Small lipid droplets 
appeared within the cytoplasm of the cells first 
on days 3 to 4; they gradually occupied the 
whole cells by day 21. The lipid droplets 
turned into red when stained by the oil red 
staining method (Figure 2C). RT-PCR analysis 
was also indicative of the expression of PPAR 
alpha (Peroxisome proliferator’s activated-
receptor alpha), PPAR gamma (Peroxisome 
proliferator’s activated-receptor gamma), LPL 
and LPL (lipoprotein lipase) genes (Figure 2D). 
  In the micro mass culture system for 
chondrocyte differentiation, the size of the 
pellet seemed to have increased during the 
culture period, probably as a result of matrix 
production and secretion. Metachromatic 
nature of the matrix was demonstrated by the 
toluidine blue staining method (Figure 2E), 
and its marker molecules including aggrecan, 
Collagen II and Collagen X were examined by 
RT-PCR analysis (Figure 2F). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Multilineage differentiation potential of the 
isolated cells. Passage-3 cultures were easily 
differentiated among bone (A-B), cartilage (C-D) and 
adipose (E-F) cells. Differentiation into the skeletal cell 
lineage is considered to be as defining criterion for the 
cells. 
 
Culture optimization 
Seeding density 
The maximum fold increase in cell number 
was achieved when the cells were plated at 
100 cell/cm
2 (Figure 3, upper graph). At this 
point, their difference in comparison to the 
groups of 10, 50, 200 and 500 cell/cm
2 was 
statistically significant (P<0.01). 
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Figure 3. Optimization of the culture conditions for 
extensive proliferation of the cells. Passage-3 goat 
MSCs possessed maximum proliferation when they 
were plated at 100 cells/ cm
2 (upper graph) in a medium 
supplemented with 15% FBS (lower graph). * indicates 
a statistically higher value (P<0.05). 
 
Serum concentration 
The cells having been plated with 15% FBS 
had a significantly larger fold increase in cell 
number as compared to those having been 
plated with 5%, 10% and 20% FBS (Figure 3, 
lower graph).   
 
CFU-F Assay Results  
Almost 58.8 clones, each consisting of 20-70 
cells, formed by per 100 cells plated  in             
25-cm
2 flasks for 6 days  
 
Population doubling time (PDT) 
Population of passaged-3 goat MSCs appeared 
to have a rather high expansion rate, so that 
their number was doubled in average of 
24.94±2.67 hr when plated at 100 cells/cm
2 in 
a medium supplemented with 15% FBS. 
 
Discussion 
In this study, we culture-expanded the cells 
from goat marrow and evaluated them whether 
or not they were able to produce specialized 
lineages as bone, cartilage and adipose cells. 
The studied cells appeared to be mesenchymal 
stem cells in nature because they successfully 
differentiated into the skeletal cell lineages. It 
should be mentioned that since investigators 
have reported studies of MSC, using different 
methods of isolation and expansion, and 
different approaches to characterizing the cells, 
thus it is increasingly difficult to compare and 
contrast study outcomes which hinders 
progress in the field. To address this issue 
mesenchymal and tissue stem cell committee 
of international society for cellular therapy has 
proposed the ability of multilineage 
differentiation as defining criterion for MSCs 
(13). In a few related investigations that have 
previously been conducted, these important 
defining characteristics have been ignored; 
hence, it was not clear that the cells having 
been used by those researchers were the MSC 
in nature. In the present study multilineage 
differentiation capacity of marrow-derived 
goat MSCs were examined and confirmed. 
In addition to its significance as a defining 
criterion for MSCs, in vitro differentiation of 
MSCs would be of great clinical value. In cell 
therapy strategies; it is believed that 
transplanted cells should be of terminally 
differentiated lineages otherwise they would 
produce non specific cells in defect site             
(17-18). Therefore, in vitro differentiations of 
the cells into interest cells could be a necessary 
step prior to their transplantation. In this study 
the potential of goat MSC in vitro 
differentiation which has not gained attention 
at former investigations were explored.  
The other point of the present study was the 
issue of the lack of a number of goat bones, 
cartilage and adipose cell-specific gene 
sequences in NCBI gene database. To solve 
this problem, we used the primers designed for 
equine corresponding genes and amplified the 
genes in differentiated cultures of goat MSC 
and then extracted the products and sequenced 
them. Our further examination by BLAST 
software indicated the similarity of the 
sequenced products with known sequence of 
the genes in several species. Therefore, we 
concluded that they would be the sequence 
that would be conserved in the species. The 
sequences were then registered at NCBI gene  
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database and were gained an accession number 
indicated in Table 1.  
 MSCs are being considered as valuable tool 
for regenerative medicine. The preclinical 
development of therapeutic procedures, using 
MSCs requires sufficient animal studies both 
for safety and for the investigation of efficacy 
of the cells. In this regard, the investigation of 
MSC in large animals would be of great 
importance since in contrast to rodents they 
are genetically more closely related to humans. 
Results from large animal models have been 
much more predictive with regard to human 
clinical trials than have results from in vitro 
assays or rodent models. Furthermore, one 
limitation associated with mice as a model is 
their limited life expectancies that preclude 
long-term follow-up (19, 20).  Given the 
significance of large animal model in stem cell 
investigation, in this study MSCs from goat 
bone marrow were isolated and characterized. 
This has not been performed at related 
previous investigations.  
MSCs occur at low frequencies in bone 
marrow samples (21). On the other hand they 
are needed in large numbers in most 
experimental set up. As a solution, MSCs 
should be expanded in culture before they are 
being used at any application. MSC ex vivo 
propagation is largely dependent on the 
presence of FBS in culture medium. 
According to former researches, MSCs that are 
developed in mediums containing FBS would 
be immunogenic and may transfer bovine 
pathogens upon transplantation (19). In spite 
of extensive attempt that has been made to 
substitute the bovine serum, less success has 
been achieved (21, 22). In this study, therefore, 
goat MSCs were cultivated in different 
concentrations of FBS to determine the least 
concentration with the highest mitogenic effect, 
which this was achieved by 15% FBS in the 
medium. 
In the present study, the best cell density at 
culture initiation which resulted in extensive 
proliferation of the cells was determined. This 
is of utmost importance especially at cell 
therapy strategies where the rapid expansion of 
cells would be desired. According to our data, 
goat MSCs possessed the highest fold increase 
when being cultivated at 100 cells/ cm
2. In a 
study by Bartmann et al it has been reported 
that there would be an inverse correlation 
between human MSC seeding density and their 
proliferation (23). Our results seem to be 
differed from those of Bartmann et al in that, 
although, the culture with the least cell 
concentration showed the highest 
proliferations, but in culture with 2000 cells/ 
cm
2 there appeared to be more proliferation 
than in culture with 500 and 1000 cells/cm
2. 
This discrepancy would be the results of 
different species from which the cells obtained 
(human versus goat). Such results, however, 
can be used to optimize the goat culture 
condition for maximum proliferation of the 
cells. 
In spite of the considerable attempts that 
have been made to define the antigenic profile 
of human MSCs, no definitive single marker 
has so far been introduced. In this regard, 
several markers including CD133, LNGFR 
(low affinity nerve growth factor receptor) and 
STRO-1 have been proposed as markers of 
human MSCs (24-26). However, the 
identification of MSCs, especially those from 
animal source would be a difficult task owing 
to the lack of distinct specific marker. To 
overcome this problem, MSCs committee of 
the international society for cell therapy has 
proposed that MSCs from animal source 
should possess two characteristic criteria: a) 
they must be adherent on plastic surfaces of 
culture dish. b) They must be able to produce 
bone, cartilage and adipose cell lineages (13). 
Since the isolated cells of the present study 
were easily differentiated into bone, cartilage 
and adipose cells and also they were plastic 
adherent cells, we convinced that they were 
the MSCs described elsewhere. 
 
Conclusion 
Taken together, fibroblastic cells developed at 
marrow cell culture of goat are able to 
differentiate into skeletal linage as bone 
cartilage and adipose cells, hence, they are 
MSCs described elsewhere. According to our 
findings, the best culture condition for 
maximum proliferation of goat MSCs would  
Mohamadreza Baghaban Eslaminejad et al 
Iran J Basic Med Sci, Vol. 12, No. 2, Summer 2009    78 
be achieved when the cells were plated at         
100 cells/cm
2 in a medium containing 15% FBS. 
Furthermore, in this study, we identified the 
sequences of a number of goat genes which were 
not present in NCBI gene database. The genes 
were registered and gained an accession number. 
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